Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.59 |
| ▸ | ZDHHC2 | Q9UIJ5 | 3/20 | 0.59 |
| ▸ | EGFR | P00533 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.53 |
| ▸ | CASP2 | P42575 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 2/20 | 0.47 |
| ▸ | HTR2C | P28335 | 2/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | HTR7 | P34969 | 1/20 | 0.47 |
| ▸ | HTR6 | P50406 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30849149 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL7047418 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL11367039 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL1824294 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL5432087 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL7882823 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL7129938 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL9461784 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL7129948 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 | |
| SCHEMBL7564411 | 1.00 | ZDHHC20 (0.59) | ZDHHC20ZDHHC2EGFREPHX1CASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8829116-B2 | Method for producing block copolymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-09-09 | — | — | US | disclosed |
| US-8486428-B2 | Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-07-16 | — | — | US | disclosed |
| EP-2444426-B1 | Method for producing block copolymers | ROHM & HAAS (US) | 2013-05-01 | — | — | EP | disclosed |
| US-20120101218-A1 | METHOD FOR PRODUCING BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC | 2012-04-26 | — | — | US | disclosed |
| EP-2444426-A1 | Method for producing block copolymers | Rohm and Haas Company (US) | 2012-04-25 | — | — | EP | disclosed |
| WO-2007126775-A2 | COMPOSITIONS AND METHODS FOR MAKING AND USING ACYCLIC N-HALAMINE-BASED BIOCIDAL POLYMERIC MATERIALS AND ARTICLES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-11-08 | — | — | WO | disclosed |
| US-20070224161-A1 | Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-09-27 | — | — | US | disclosed |
| US-7008990-B2 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-07 | — | — | US | disclosed |
| US-6902810-B1 | Mesomorphic polyelectrolyte complexes prepared by reacting, in a liquid pahse a polymeric and oligomeric, anionic polyelectrolyte with a polymeric oligomeric, organic cationic polyelectrolyte and cationic surfactant | BASF COATINGS AG (DE) | 2005-06-07 | — | — | US | disclosed |
| US-6815498-B2 | BLOCK POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-09 | — | — | US | disclosed |
| US-6790909-B2 | INITIATOR FUNCTIONS SUITABLE FOR CATIONIC POLYMERIZATION INTO THE MACROINITIATOR. EXAMPLES OF SUCH INTERESTING INITIATOR FUNCTIONS ARE GROUPS CONTAINING HALOGEN OR SULFONYL CHLORIDE | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-14 | — | — | US | disclosed |
| US-6716905-B1 | AQUEOUS DISPERSION OF A STILBENE DERIVATIVE POLYMER MADE USING A FREE RADICAL CATALYST | COATINGS AG (DE) | 2004-04-06 | — | — | US | disclosed |
| US-20040034182-A1 | Method for the production of a polymerisation reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-19 | — | — | US | disclosed |
| US-20040024145-A1 | Graft copolymers, their preparation and their use | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-05 | — | — | US | disclosed |
| US-20040014872-A1 | Bonding agent composition containing solid matter, with radically polymerised block copolymers | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-22 | — | — | US | disclosed |
| US-20030170306-A1 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-11 | — | — | US | disclosed |
| US-20030018137-A1 | Method for producing a polymeric conversion product | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070224161-A1 | Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles | NAAA, NIT2, AADAC | ZDHHC20 308/4885ZDHHC2 1095/4885EGFR 1063/4885 |
| US-20030170306-A1 | Use of polymeric reaction product | OXSR1, OGFR, CBR1 | ZDHHC20 3928/4885ZDHHC2 3692/4885EGFR 962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.